4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000211
Director sold 646 shares at $500.00 ($323,000)
- Director acquired 646 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bhatia Sangeeta N. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +646 | $152.74 | $98,670 | 5,081 | D |
| 2024-08-30 | Sale : show line 2 in the form 10b5-1 | −646 | $500.00 | $323,000 | 4,435 | D |
| Open-market sales · 646 sh · avg $500.00 · $323,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-08-30 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −646 | $152.74 | 2028-05-31 | 646 | 0 | D |
Loading xslF345X05/wk-form4_1725480753.xml…